Alexander H. Glassman
#139,640
Most Influential Person Now
Alexander H. Glassman's AcademicInfluence.com Rankings
Alexander H. Glassmanphilosophy Degrees
Philosophy
#7237
World Rank
#10423
Historical Rank
Logic
#4298
World Rank
#5570
Historical Rank
Download Badge
Philosophy Biology
Alexander H. Glassman's Degrees
- Doctorate Medicine Columbia University
Why Is Alexander H. Glassman Influential?
(Suggest an Edit or Addition)Alexander H. Glassman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sertraline treatment of major depression in patients with acute MI or unstable angina (2002) (1400)
- Smoking, smoking cessation, and major depression. (1990) (1220)
- Mood Disorders in the Medically Ill: Scientific Review and Recommendations (2005) (1009)
- Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. (2001) (790)
- Depressed Affect, Hopelessness, and the Risk of Ischemic Heart Disease in a Cohort of U.S. Adults (1993) (784)
- Depression and the course of coronary artery disease. (1998) (712)
- Cigarette smoking: implications for psychiatric illness. (1993) (704)
- Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. (1988) (461)
- Smoking cessation and the course of major depression: a follow-up study (2001) (387)
- Platelet/Endothelial Biomarkers in Depressed Patients Treated With the Selective Serotonin Reuptake Inhibitor Sertraline After Acute Coronary Events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy (2003) (344)
- Depression and depressive symptoms in smoking cessation. (1990) (329)
- Cigarette smoking and major depression. (1998) (304)
- Clinical implications of imipramine plasma levels for depressive illness. (1977) (292)
- Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. (1994) (279)
- Major depression following smoking cessation. (1997) (264)
- The dexamethasone suppression test: An overview of its current status in psychiatry (1987) (247)
- Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. (1981) (238)
- The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. (1993) (225)
- Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. (2009) (217)
- Cigarette craving, smoking withdrawal, and clonidine. (1984) (217)
- Delusional depression. A distinct clinical entity? (1981) (216)
- Cardiovascular effects of fluoxetine in depressed patients with heart disease. (1998) (211)
- Depression, Delusions, and Drug Response. (1975) (210)
- Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers (1993) (177)
- Depression, delusions, and suicide. (1983) (172)
- Cardiac antiarrhythmic effect of imipramine hydrochloride. (1977) (171)
- Contribution of genetic and nutritional factors to DNA damage in heavy smokers. (1997) (162)
- Cardiovascular effects of bupropion in depressed patients with heart disease. (1991) (160)
- An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial. (1999) (159)
- The Electrocardiographic and Antiarrhythmic Effects of Imipramine Hydrochloride at Therapeutic Plasma Concentrations (1979) (158)
- Potentiation of a monoamine oxidase inhibitor by tryptophan. (1969) (157)
- Bulimia and Depression (1985) (148)
- Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. (2006) (142)
- CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSION (1979) (137)
- Assessment and treatment of depression in patients with cardiovascular disease: National heart, lung, and blood institute working group report (2006) (137)
- Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study. (1984) (135)
- Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action (2004) (131)
- Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. (2003) (127)
- Tricyclic antidepressants in depressed patients with cardiac conduction disease. (1987) (126)
- The use of antidepressant drugs in patients with heart disease. (1998) (120)
- Phenelzine vs placebo in 50 patients with bulimia. (1988) (112)
- Naltrexone effects on short-term and long-term smoking cessation. (1999) (110)
- Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trials (2003) (109)
- Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. (2006) (108)
- The use of imipramine in depressed patients with congestive heart failure. (1983) (108)
- Effect of history of alcoholism or major depression on smoking cessation. (1993) (106)
- Cardiovascular effects of tricyclic antidepressants. (1987) (106)
- Delusional Depressions: Natural History and Response to Treatment (1977) (104)
- Cardiovascular effects of antidepressant drugs: updated (1998) (100)
- Ever-smoking, quitting, and psychiatric disorders: evidence from the Durham, North Carolina, Epidemiologic Catchment Area (1994) (100)
- Tricyclic nonresponders: phenomenology and treatment. (1986) (97)
- Depression and cardiovascular comorbidity (2007) (95)
- Review of the cardiovascular effects of heterocyclic antidepressants. (1993) (93)
- A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. (2002) (92)
- Heart rate variability in acute coronary syndrome patients with major depression: influence of sertraline and mood improvement. (2007) (92)
- A meta-analysis of double-blind placebo-controlled trials of clonidine for smoking cessation. (1991) (90)
- Imipramine-induced heart block. A longitudinal case study. (1975) (83)
- Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure. (1987) (83)
- Depression and ischemic heart disease: what have we learned so far and what must we do in the future? (2005) (81)
- Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference. (1981) (81)
- The cardiac effects of therapeutic plasma concentrations of imipramine. (1978) (81)
- Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual-wavelength ultraviolet detection. (1984) (80)
- Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depression. (2005) (76)
- Treatment of Bulimia with Monoamine Oxidase Inhibitors (1982) (76)
- Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment. (2002) (76)
- Schizophrenia, antipsychotic drugs, and cardiovascular disease. (2005) (75)
- Relationship between depression and other medical illnesses. (2001) (73)
- Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. (1994) (72)
- Selective serotonin reuptake inhibitors yield additional antiplatelet protection in patients with congestive heart failure treated with antecedent aspirin (2003) (72)
- Mood, major depression, and fluoxetine response in cigarette smokers. (1995) (71)
- Plasma binding of imipramine and clinical outcome. (1973) (70)
- EEG-monitored sleep in anorexia nervosa and bulimia (1985) (68)
- Antidepressant Drug Effects and Depression Severity: A (2010) (67)
- Depression and nicotine: Preclinical and clinical evidence for common mechanisms (2001) (66)
- Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia (1987) (64)
- Depression, heart disease, and tricyclic antidepressants. (1989) (62)
- Reversible loss of nocturnal penile tumescence during depression: a preliminary report. (1982) (60)
- Nortriptyline in depressed patients with left ventricular impairment. (1986) (59)
- Depression after smoking cessation: case reports. (1996) (59)
- Where There Is Depression, There Is Inflammation․․․Sometimes! (2007) (55)
- The dexamethasone suppression test in bulimia. (1985) (51)
- Indoleamines and Affective Disorders (1969) (49)
- Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. (2008) (47)
- A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse. (2007) (45)
- Diminished cardiac vagal tone in schizophrenia: Associations to brain laterality and age of onset (1997) (45)
- Hypothalamic-pituitary-gonadal function in Anorexia Nervosa and Bulimia (1989) (44)
- Risks of antidepressants in the elderly: tricyclic antidepressants and arrhythmia-revising risks. (1994) (43)
- The clinical pharmacology of imipramine. Implications for therapeutics. (1973) (42)
- A double-blind trial of phenelzine in bulimia. (1985) (42)
- Low Heart Rate Variability Is Not Caused by Typical Neuroleptics in Schizophrenia Patients (2002) (42)
- Dr. Glassman and Associates Reply (1975) (39)
- Negative sodium balance in lithium carbonate toxicity. Evidence of mineralocorticoid blockade. (1973) (39)
- Depression as a risk factor for post-MI mortality. (2004) (38)
- Cardiovascular Health and Depression (2003) (37)
- Dexamethasone suppression test and plasma dexamethasone levels in bulimia. (1987) (33)
- Smoking and Depression: A Co-morbidity (2009) (33)
- Blood pressure effects of phenelzine. (1983) (32)
- A Distinct Clinical Entity (2016) (29)
- Does treating post-myocardial infarction depression reduce medical mortality? (2005) (29)
- Is doxepin a safer tricyclic for the heart? (1991) (28)
- Cardiovascular toxicity of antidepressant medications. (1987) (26)
- Treatment strategies for refractory depression (1990) (25)
- The American Heart Association science advisory on depression and coronary heart disease: An exploration of the issues raised (2010) (25)
- Tricyclic antidepressants in depressed patients with cardiac conduction disease (1988) (24)
- Psychiatry and cigarettes. (1998) (23)
- Cardiovascular effects of antidepressant drugs: updated. (1998) (23)
- Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction. (2005) (23)
- Treatment of Depression in Patients with Heart Disease (1998) (22)
- Antidepressants in coronary heart disease: SSRIs reduce depression, but do they save lives? (2007) (22)
- An open trial of MAO inhibitors in bulimia. (1984) (21)
- Plasma levels and tricyclic antidepressants (1974) (21)
- Depression and Heart Disease (1997) (21)
- Cardiovascular effects of antidepressant drugs (1993) (20)
- Depression, Cardiac Death, and the Central Nervous System (1998) (20)
- Treatment of bulimia with monoamine oxidase inhibitors. (1983) (20)
- Factors related to orthostatic hypotension associated with tricyclic antidepressants. (1982) (20)
- Clinical management of cardiovascular risks during treatment with psychotropic drugs. (2002) (17)
- A clinical approach to help psychiatric patients with smoking cessation (2005) (16)
- Advances in Non-Nicotine Pharmacotherapy for Smoking Cessation (2012) (16)
- Plasma levels of imipramine in depression. Environmental and genetic factors. (1976) (16)
- Depression and cardiovascular disease. (2008) (16)
- Plasma levels of imipramine and clinical outcome. (1975) (15)
- Psychoactive smoke (1996) (15)
- Cardiovascular toxicity and tricyclic antidepressants. (1987) (15)
- Cardiovascular effects of the standard tricyclic antidepressants. (1988) (15)
- Desmethylimipramine and imipramine on left ventricular function and the ECG: a randomized crossover design. (1983) (14)
- A controlled trial of phenelzine in bulimia. (1987) (14)
- Is physostigmine effective for cardiac toxicity of tricyclic antidepressant drugs. (1977) (12)
- Tricyclics and heart failure. (1991) (12)
- Adverse effects of tricyclic antidepressants: focus on the elderly. (1984) (11)
- CIGARETTE SMOKING, MAJOR DEPRESSION, AND SCHIZOPHRENIA (1992) (10)
- Antidepressant plasma levels revisited (1994) (10)
- Link between bulimia and depression unclear. (1983) (10)
- Studies on plasma level/effect relationships in imipramine therapy. (1978) (9)
- Tricyclics and heart failure. (1991) (8)
- A correlational study of cardiovascular autonomic functioning and unipolar depression. (1983) (8)
- Cigarette smoking and its comorbidity. (1997) (7)
- The newer antidepressant drugs and their cardiovascular effects. (1984) (7)
- Sleep and growth hormone secretion in women athletes. (1984) (7)
- Lactate infusions in patients with bulimia (1988) (6)
- Effects of imipramine on chromosomes in psychiatric patients. (1978) (6)
- Depressed Patients with Cardiovascular Disease (1994) (6)
- Citalopram toxicity (1997) (4)
- Future Trends in the Pharmacological Treatment of Smoking Cessation (1990) (4)
- Depression and Cardiovascular Disease: The Safety of Antidepressant Drugs and their Ability to Improve Mood and Reduce Medical Morbidity (2010) (4)
- Tricyclic drugs in the treatment of depression. (1982) (4)
- Depression and Heart Disease: Glassman/Depression and Heart Disease (2010) (4)
- Drs. Glassman and Bigger Reply (2002) (4)
- DEPRESSION AFTER CORONARY ARTERY BYPASS GRAFT SURGERY (1998) (4)
- Glassman AH, Roose SP, Rivelli SK. Preud'homme XA. Cardiovascular effects of antide- pressant drugs. Nord J Psychiatry 1993;47 Suppl 30:41-47. Oslo. ISSN 080.3-9496. (1993) (3)
- Imipramine and delusional depressions. (1979) (3)
- Imipramine steady-state studies and plasma binding. (1974) (3)
- The Use Of Tricyclic Antidepressant Drugs In Geriatric Patients (1980) (3)
- Blood-Level Measurements of Tricyclic Drugs as a Diagnostic Tool (1981) (3)
- An Examination of the Linkage Between Ischemic Heart Disease and Depression (2001) (3)
- Subtrochanteric pathological fracture of both femora secondary to malignant pheochromocytoma. A case report. (1990) (3)
- Delusional depression: tricyclic response. (1986) (2)
- Depressed Patients with Cardiovasc,ular Disease Treatment Considerations (1994) (2)
- Cardiovascular effects of the tricyclic antidepressants: implications for new research (1981) (2)
- The implications of left ventricular performance for tricyclic antidepressant drug treatment (1983) (2)
- The safety of antidepressant drugs in cardiovascular disease (1993) (2)
- Tricyclic antidepressant drug tolerance in Oriental and Occidental populations. (1979) (2)
- Effects of zoloft® on platelet/endothelial biomarkers in depressed patients after acute coronary events: Sertraline Anti-Depressant Heart Attack Randomized Trial (SADHART platelet substudy) (2002) (2)
- Academic Highlights: Managing Patients With Vascular Disease and Depression. [CME] (2006) (2)
- ANTIDEPRESSANTS IN THE CARDIAC PATIENT (1992) (2)
- A DOUBLE-BLIND TRIAL OF PHENELZINE IN BULIMIA (1986) (2)
- Introduction. Optimizing clinical use of SSRIs: theory and practice. (1998) (2)
- 2-2 Death, depression and heart disease in late-life (1997) (1)
- Book Review Nicotine Safety and Toxicity Edited by Neal L. Benowitz. 203 pp. New York, Oxford University Press, 1998. $55. 0-19-511496-5 (1999) (1)
- Depression severity and effect of antidepressant medications. (2010) (1)
- Overdose With Tricyclic Drugs (1987) (1)
- Prolongation of QTc interval and antipsychotics. Authors' reply (2002) (1)
- Use of Antidepressants in the Geriatric Population (1984) (1)
- Dr. Karasu and Colleagues Reply (1994) (1)
- Contents, Vol. 20, Supplement 1, 1987 (1987) (0)
- Keep up with Critical Fields (2010) (0)
- Heavy Smokers, Smoking Cessation, and Clonidine-Reply (1988) (0)
- Depression Severity and Effect of Antidepressant Medications. Authors' reply (2010) (0)
- QUESTION THE EXPERTS (1985) (0)
- Contents, Vol. 8, 1982 (1982) (0)
- Quality of life and health care costs post MI: influence of depression and effect of treatment with sertraline (2003) (0)
- Comprar Depression And Heart Disease | Alexander Glassman | 9780470710579 | Wiley (2010) (0)
- S-5-1 Depression and the risk of mortality (1995) (0)
- Contents of the American Journal of Psychiatry (1995) (0)
- Smoking cessation treatments: measuring responses among ethnic groups. (2008) (0)
- S-76-2 Psychiatric illness & cigarette smoking (1996) (0)
- P.1.037 Quality of life post MI: Influence of depression and effect of treatment with sertraline (2003) (0)
- S.23.05 Vascular disease and depression: clinical management (2007) (0)
- [The central nervous system, depression and cardiac death]. (1997) (0)
- Plasma level of antidepressant drug and outcome: the state of the art (1976) (0)
- Neuropharmacology. Psychoactive smoke. (1996) (0)
- S-21-4 Mechanisms linking death and depression (1995) (0)
- Modern tricyclic antidepressant drugs are hardly distinguishable in efficacy or safety for treatment of depressive mood disorders in controlled clinical trials. (1993) (0)
- ANTIDERPRESSANTS IN THE CARDIAC PATIENT (1984) (0)
- S-5-3 SSRIs in the treatment of melancholic patients (1995) (0)
- Cimetidine-Imipramine Interaction: Case Report and Comments (1984) (0)
- Reply to Kleespies (1993) (0)
- Treatment of major depression after acute coronary syndromes (ACS): Myocardial infarction or unstable angina: Sadhart trial (2000) (0)
- Depression, Ischemic Heart Disease and Mortality (1997) (0)
- Title Page / Table of Contents, Supplement 1, 1994 (1994) (0)
- Dr. Glassman Replies (1994) (0)
- S-21-5 Can antidepressants be used safely in patients with serious heart disease? (1995) (0)
- P.1.201 Cost reduction implications of sertraline treatment for depression after acute coronary syndromes (2003) (0)
- Subject Index Vol. 8, 1982 (1982) (0)
- Novel Therapeutic Indications of Antidepressant Drugs (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alexander H. Glassman?
Alexander H. Glassman is affiliated with the following schools:
